Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers

Condition:   Healthy Interventions:   Combination Product: Janumet XR tablet 100/1000 mg;   Combination Product: GLH1SM tablet 100/1000 mg Sponsor:   GL Pharm Tech Corporation Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials